Lv3
380 积分 2024-10-14 加入
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria
2小时前
待确认
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
3小时前
已完结
Updated efficacy and safety results from the phase 2 study of timdarpacept in combination with tislelizumab in patients with classical Hodgkin lymphoma for whom prior anti–PD-1 therapy failed
8天前
已完结
Phase 1/2 Trial of Anti-CD7 Allogeneic WU-CART-007 in patients with Relapsed/Refractory T-cell Malignancies
9天前
已完结
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance
10天前
已完结
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
10天前
已完结
Cytomolecular Mechanisms of Relapse and Post‐Relapse Outcomes After Frontline FLT3 Inhibitor‐Based Therapy in FLT3‐Mutated AML
11天前
已完结
Discovery of Potent Dual PROTAC Degraders Targeting BET-Kinase To Overcome FLT3 Inhibitor Resistance
11天前
已完结
From one to many gene therapies
13天前
已完结
Association of Pre-Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer
13天前
已完结
皖公网安备34019202002308
